Search by Drug Name or NDC

NDC 00173-0906-13 Jesduvroq 4 mg/1 Details

Jesduvroq 4 mg/1

Jesduvroq is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is DAPRODUSTAT.

MedlinePlus Drug Summary

Daprodustat is used to treat anemia (a lower than normal number of red blood cells) in people with chronic kidney failure (condition in which the kidneys slowly and permanently stop working over a period of time) who have been receiving hemodialysis for at least 4 months Daprodustat is in a class of medications called HIF PH inhibitors. It works by increasing the hormone, erythropoietin, needed by the body to produce more red blood cells.

Related Packages: 00173-0906-13
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Daprodustat

Product Information

NDC	00173-0906
Product ID	0173-0906_c6714341-ff44-4178-8c1d-2ba8fc4d6be1
Associated GPIs
GCN Sequence Number	084380
GCN Sequence Number Description	daprodustat TABLET 4 MG ORAL
HIC3	N1J
HIC3 Description	HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INH.
GCN	53675
HICL Sequence Number	048668
HICL Sequence Number Description	DAPRODUSTAT
Brand/Generic	Brand
Proprietary Name	Jesduvroq
Proprietary Name Suffix	n/a
Non-Proprietary Name	daprodustat
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	4
Active Ingredient Units	mg/1
Substance Name	DAPRODUSTAT
Labeler Name	GlaxoSmithKline LLC
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA216951
Listing Certified Through	2024-12-31

Package

NDC 00173-0906-13 (00173090613)

Pricing Information	N/A
NDC Package Code	0173-0906-13
Billing NDC	00173090613
Package	30 TABLET, FILM COATED in 1 BOTTLE (0173-0906-13)
Marketing Start Date	2023-02-01
NDC Exclude Flag	N